Found 4 hits for monomerid = 50194685 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50194685
(CHEMBL385055 | N-(2-(3,3-dimethyl-2-oxoazetidin-1-...)Show SMILES CNc1ncc2cc(ccc2n1)-c1cc(ccc1C)C(=O)Nc1cc(ccc1N1CC(C)(C)C1=O)C(F)(F)F Show InChI InChI=1S/C29H26F3N5O2/c1-16-5-6-18(12-21(16)17-7-9-22-19(11-17)14-34-27(33-4)36-22)25(38)35-23-13-20(29(30,31)32)8-10-24(23)37-15-28(2,3)26(37)39/h5-14H,15H2,1-4H3,(H,35,38)(H,33,34,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 172 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen, Inc.
Curated by ChEMBL
| Assay Description Inhibition of p38-alpha by HTRF kinase assay |
J Med Chem 49: 5671-86 (2006)
Article DOI: 10.1021/jm0605482 BindingDB Entry DOI: 10.7270/Q29G5MFD |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50194685
(CHEMBL385055 | N-(2-(3,3-dimethyl-2-oxoazetidin-1-...)Show SMILES CNc1ncc2cc(ccc2n1)-c1cc(ccc1C)C(=O)Nc1cc(ccc1N1CC(C)(C)C1=O)C(F)(F)F Show InChI InChI=1S/C29H26F3N5O2/c1-16-5-6-18(12-21(16)17-7-9-22-19(11-17)14-34-27(33-4)36-22)25(38)35-23-13-20(29(30,31)32)8-10-24(23)37-15-28(2,3)26(37)39/h5-14H,15H2,1-4H3,(H,35,38)(H,33,34,36) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen, Inc.
Curated by ChEMBL
| Assay Description Inhibition of Lck by HTRF kinase assay |
J Med Chem 49: 5671-86 (2006)
Article DOI: 10.1021/jm0605482 BindingDB Entry DOI: 10.7270/Q29G5MFD |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50194685
(CHEMBL385055 | N-(2-(3,3-dimethyl-2-oxoazetidin-1-...)Show SMILES CNc1ncc2cc(ccc2n1)-c1cc(ccc1C)C(=O)Nc1cc(ccc1N1CC(C)(C)C1=O)C(F)(F)F Show InChI InChI=1S/C29H26F3N5O2/c1-16-5-6-18(12-21(16)17-7-9-22-19(11-17)14-34-27(33-4)36-22)25(38)35-23-13-20(29(30,31)32)8-10-24(23)37-15-28(2,3)26(37)39/h5-14H,15H2,1-4H3,(H,35,38)(H,33,34,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen, Inc.
Curated by ChEMBL
| Assay Description Inhibition of KDR by HTRF kinase assay |
J Med Chem 49: 5671-86 (2006)
Article DOI: 10.1021/jm0605482 BindingDB Entry DOI: 10.7270/Q29G5MFD |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50194685
(CHEMBL385055 | N-(2-(3,3-dimethyl-2-oxoazetidin-1-...)Show SMILES CNc1ncc2cc(ccc2n1)-c1cc(ccc1C)C(=O)Nc1cc(ccc1N1CC(C)(C)C1=O)C(F)(F)F Show InChI InChI=1S/C29H26F3N5O2/c1-16-5-6-18(12-21(16)17-7-9-22-19(11-17)14-34-27(33-4)36-22)25(38)35-23-13-20(29(30,31)32)8-10-24(23)37-15-28(2,3)26(37)39/h5-14H,15H2,1-4H3,(H,35,38)(H,33,34,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 193 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen, Inc.
Curated by ChEMBL
| Assay Description Inhibition of Jak3 by HTRF kinase assay |
J Med Chem 49: 5671-86 (2006)
Article DOI: 10.1021/jm0605482 BindingDB Entry DOI: 10.7270/Q29G5MFD |
More data for this Ligand-Target Pair | |